By Drug Target Review2025-02-04T08:00:04
A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides that can bind to and destroy previously untreatable proteins.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-05-03T15:39:23
Sponsored by BPS Bioscience
2023-02-07T15:25:20
Sponsored by Bio-Techne
2024-02-07T14:34:33
Sponsored by BellBrook Labs
Site powered by Webvision Cloud